par Beyer, Ingo ;Bautmans, I;Njemini, R;Demanet, Christian;Bergmann, Pierre ;Mets, Tony
Référence BMC musculoskeletal disorders, 12, page (292)
Publication Publié, 2011
Référence BMC musculoskeletal disorders, 12, page (292)
Publication Publié, 2011
Article révisé par les pairs
Titre: |
|
Auteur: | Beyer, Ingo; Bautmans, I; Njemini, R; Demanet, Christian; Bergmann, Pierre; Mets, Tony |
Informations sur la publication: | BMC musculoskeletal disorders, 12, page (292) |
Statut de publication: | Publié, 2011 |
Sujet CREF: | Médecine clinique [biologie clinique] |
Endocrinologie | |
Médecine pathologie humaine | |
Mots-clés: | cytokines |
heat shock protein | |
muscle performance | |
NSAID | |
piroxicam | |
MeSH keywords: | Age Factors |
Aged | |
Aged, 80 and over | |
Anti-Bacterial Agents -- therapeutic use | |
Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use | |
Belgium | |
Chi-Square Distribution | |
Communicable Diseases -- complications -- diagnosis -- drug therapy -- metabolism -- physiopathology | |
Cytokines -- blood | |
Double-Blind Method | |
Female | |
Geriatric Assessment | |
HSP27 Heat-Shock Proteins -- metabolism | |
HSP70 Heat-Shock Proteins -- metabolism | |
Hand Strength | |
Hospitalization | |
Humans | |
Inflammation -- diagnosis -- drug therapy -- etiology -- metabolism -- physiopathology | |
Male | |
Muscle Fatigue -- drug effects | |
Muscle Strength -- drug effects | |
Muscle, Skeletal -- drug effects -- metabolism -- physiopathology | |
Piroxicam -- therapeutic use | |
Placebos | |
Time Factors | |
Treatment Outcome | |
Note générale: | Journal Article |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1471-2474 |
info:doi/10.1186/1471-2474-12-292 | |
info:pii/1471-2474-12-292 | |
info:scp/84855163838 | |
info:pmid/22208783 | |
PMC3273447 |